Concurrent Investment Advisors’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-75,600
Closed -$357K 2005
2025
Q4
$357K Buy
75,600
+23,300
+45% +$104K ﹤0.01% 1299
2025
Q3
$251K Buy
52,300
+42,000
+408% +$165K ﹤0.01% 1240
2025
Q2
$24.8K Buy
10,300
+10,000
+3,333% +$24.6K ﹤0.01% 1371
2025
Q1
$783 Sell
300
-52,000
-99% -$168K ﹤0.01% 1236
2024
Q4
$199K Sell
52,300
-30,500
-37% -$165K 0.01% 997
2024
Q3
$594K Buy
82,800
+77,800
+1,556% +$553K 0.02% 586
2024
Q2
$36.6K Buy
5,000
+1,300
+35% +$11.3K ﹤0.01% 946
2024
Q1
$37K Sell
3,700
-2,400
-39% -$21K ﹤0.01% 880
2023
Q4
$42.8K Buy
+6,100
New +$40.6K ﹤0.01% 834

Other funds holding MSOS

Concurrent Investment Advisors's MSOS Position: Q1 2026 in Review

Concurrent Investment Advisors increased its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 148% in Q1 2026, buying an estimated $2.45M and bringing the position to 1,004,507 shares worth $3.57M. The position accounts for 0.04% of the portfolio, ranked #439.

Concurrent Investment Advisors first reported a position in MSOS in Q4 2023 and has held it in 10 quarters since. 168 funds tracked by Wall St. Rank hold MSOS as of Q1 2026.

  • Concurrent Investment Advisors held 1,004,507 shares of AdvisorShares Pure US Cannabis ETF worth $3.57M as of Q1 2026.
  • Concurrent Investment Advisors bought 599,031 AdvisorShares Pure US Cannabis ETF shares in Q1 2026, an estimated $2.45M.
  • AdvisorShares Pure US Cannabis ETF made up 0.04% of Concurrent Investment Advisors's portfolio in Q1 2026, its #439 holding.
  • Concurrent Investment Advisors first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2023 and has held it in 10 quarters since.
  • 168 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.